mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.8 |